“These initial results are very exciting and con
Post# of 148111
(Total Views: 388)
Posted On: 09/24/2024 8:44:25 AM
“These initial results are very exciting and confirm our belief that leronlimab has the potential to be materially beneficial for patients suffering from a number of medical concerns,” said Dr. Jacob Lalezari, CEO of CytoDyn.
Congrats to Dr J and to us all, one yard closer (maybe several) to paydirt!!!
Congrats to Dr J and to us all, one yard closer (maybe several) to paydirt!!!
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼